PX
88
13
MCO
67
3
CSCO
48
-10
STX
63
7
MCK
66
4
CAG
55
-3
MMM
13
2
NRG
37
2
CHD
32
-11
PRU
44
2
FITB
62
2
SLB
84
3
AES
62
4
ADT
55
2
PG
43
-2
VIX
24
-5
HRB
69
3
NWL
58
2
NAVI
71
3
FISV
74
2
PX
88
13
MCO
67
3
CSCO
48
-10
STX
63
7
MCK
66
4
CAG
55
-3
MMM
13
2
NRG
37
2
CHD
32
-11
PRU
44
2
FITB
62
2
SLB
84
3
AES
62
4
ADT
55
2
PG
43
-2
VIX
24
-5
HRB
69
3
NWL
58
2
NAVI
71
3
FISV
74
2
Financhill
Back

Zimmer Biomet Holdings 10K Form

Buy
84

ZBH
Zimmer Biomet Holdings

Last Price:
126.12
Seasonality Move:
4.51%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive ZBH News And Ratings

See the #1 stock for the next 7 days that we like better than ZBH

ZBH Financial Statistics

Sales & Book Value

Annual Sales: $7.84B
Cash Flow: $403.6M
Price / Cash Flow: 22.06
Annual Sales: $58.36
Price / Book: 2.15

Profitability

EPS (TTM): 1.32000
Net Income (TTM): $277.9M
Gross Margin: $5.5B
Return on Equity: 2.25%
Return on Assets: 1.24%

Zimmer Biomet Holdings Earnings Forecast

Key Zimmer Biomet Holdings Financial Ratios

  • The Gross Profit Margin over the past 22 years for ZBH is 70.13%.
  • The Selling, General & Administrative Expenses for ZBH have been equal to 42.42% of Gross Profit Margin.
  • The Research & Development expenses have been 6.34% of Revenue.
  • The Interest Expense is 51.89% of Operating Income.
  • The Net Earning history of ZBH is 5.12% of Total Revenues.
  • Per Share Earnings over the last 22 years have been positive in 13 years.

Zimmer Biomet Holdings Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: S&P500
Industry: Medical Devices
Sector: Healthcare
Current Symbol: ZBH
CUSIP: 98956P
Website: zimmerbiomet.com

Debt

Debt-to-Equity Ratio: 0.48
Current Ratio: 1.98
Quick Ratio: 0.79

Price-to-Earnings

Trailing P/E Ratio: 65.7
Forward P/E Ratio: 16.79

ZBH Technical Analysis vs Fundamental Analysis

Buy
84
Zimmer Biomet Holdings (ZBH) is a Buy

Is Zimmer Biomet Holdings a Buy or a Sell?